| NCT Number | NCT06258863 |
| Lead Sponsor | Hubei Cancer Hospital |
| Conditions | Breast Neoplasm Female |
| Enrollment | 300 participants |
| Start Date | 2023-07-18 |
| Primary Completion | 2024-07-18 (estimated) |
| Study Completion | 2025-11-18 (estimated) |
| Updated on ClinicalTrials.gov | 2025-03-17 |